PATENT CLAIM ANALYSIS

Application Number: 16249610
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["424", "204100"]

Abstract:
There is described a kit for use in inducing an immune response in a mammal, the kit includes: a first virus that expresses MAGEA3, Human Papilloma Virus E6/E7 fusion protein, human Six-Transmembrane Epithelial Antigen of the Prostate protein, or Cancer Testis Antigen 1, or a variant thereof as an antigenic protein and that is formulated to generate an immunity to the protein or variant thereof in the mammal. The kit also includes a Maraba MG1 virus encoding the same antigen, or a variant of the same antigen. The Maraba MG1 virus is formulated to induce the immune response in the mammal. The first virus is immunologically distinct from the Maraba MG1 virus.

Claim (Index 6):
The heterologous prime-boost vaccine of  claim 5 , wherein the amino acid sequence consists of SEQ ID NO: 7.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 99.0
- Lexical Diversity: 2.08475
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16249616', '14769035', '15919554', '14898083', '13257115']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7044618827798903
- 35 USC 102 Novelty (BERT): 0.6573552314230355
- Combined Prediction Score: 0.6997512176442049
- Mean Citation Score: 539.1224100000002
- Max Citation Score: 855.32
- Similarity Product: 575.3483650803565

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test